• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Serum Catestatin Levels and Arterial Stiffness Parameters Are Increased in Patients with Inflammatory Bowel Disease.炎症性肠病患者的血清抑癌素水平和动脉僵硬度参数升高。
J Clin Med. 2020 Feb 26;9(3):628. doi: 10.3390/jcm9030628.
2
Lipoprotein-associated phospholipase A2 and arterial stiffness evaluation in patients with inflammatory bowel diseases.脂蛋白相关磷脂酶A2与炎症性肠病患者的动脉僵硬度评估
J Crohns Colitis. 2014 Sep;8(9):936-44. doi: 10.1016/j.crohns.2014.01.016. Epub 2014 Feb 12.
3
Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs.炎症性肠病中动脉僵硬度增加依赖于炎症,并可被免疫调节药物降低。
Atherosclerosis. 2014 Jun;234(2):346-51. doi: 10.1016/j.atherosclerosis.2014.03.023. Epub 2014 Mar 30.
4
Urotensin II levels in patients with inflammatory bowel disease.炎症性肠病患者的尾加压素 II 水平。
World J Gastroenterol. 2021 Sep 28;27(36):6142-6153. doi: 10.3748/wjg.v27.i36.6142.
5
Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis.炎症性肠病中的动脉僵硬度:一项系统评价和荟萃分析。
J Hypertens. 2016 May;34(5):822-9. doi: 10.1097/HJH.0000000000000867.
6
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.炎症性肠病患者早期动脉粥样硬化标志物表达增加。
Eur J Intern Med. 2017 Jan;37:83-89. doi: 10.1016/j.ejim.2016.10.004. Epub 2016 Oct 21.
7
Arterial stiffness is increased in patients with inflammatory bowel disease.炎症性肠病患者的动脉僵硬度增加。
J Hypertens. 2012 Sep;30(9):1775-81. doi: 10.1097/HJH.0b013e3283568abd.
8
Pulse wave velocity measurement as a marker of arterial stiffness in pediatric inflammatory bowel disease: a pilot study.脉搏波速度测量作为儿童炎症性肠病动脉僵硬度的标志物:一项初步研究。
Eur J Pediatr. 2017 Jul;176(7):983-987. doi: 10.1007/s00431-017-2927-7. Epub 2017 May 15.
9
Pulse Wave Velocity, Intima Media Thickness, and Flow-mediated Dilatation in Patients with Normotensive Normoglycemic Inflammatory Bowel Disease.血压正常、血糖正常的炎症性肠病患者的脉搏波速度、内膜中层厚度和血流介导的血管舒张功能
Inflamm Bowel Dis. 2015 Jun;21(6):1314-20. doi: 10.1097/MIB.0000000000000355.
10
Increased pulse wave velocity and relationship with inflammation, insulin, and insulin resistance in inflammatory bowel disease.炎症性肠病中脉搏波速度增加及其与炎症、胰岛素和胰岛素抵抗的关系。
Eur J Gastroenterol Hepatol. 2014 Jul;26(7):725-32. doi: 10.1097/MEG.0000000000000104.

引用本文的文献

1
Pathophysiological Links Between Inflammatory Bowel Disease and Cardiovascular Disease: The Role of Dysbiosis and Emerging Biomarkers.炎症性肠病与心血管疾病之间的病理生理联系:肠道菌群失调及新型生物标志物的作用
Biomedicines. 2025 Jul 31;13(8):1864. doi: 10.3390/biomedicines13081864.
2
Serum Catestatin Levels and Its Relationship with Disease Activity in Patients with Ankylosing Spondylitis.强直性脊柱炎患者血清抑瘤素水平及其与疾病活动度的关系
Arch Rheumatol. 2025 Jun 23;40(2):157-163. doi: 10.5152/ArchRheumatol.2025.11014.
3
A complex role of chromogranin A and its peptides in inflammation, autoimmunity, and infections.嗜铬粒蛋白A及其肽在炎症、自身免疫和感染中的复杂作用。
Front Immunol. 2025 Apr 30;16:1567874. doi: 10.3389/fimmu.2025.1567874. eCollection 2025.
4
New Cardiovascular Risk Biomarkers in Rheumatoid Arthritis: Implications and Clinical Utility-A Narrative Review.类风湿关节炎中新的心血管风险生物标志物:意义与临床应用——一篇叙述性综述
Biomedicines. 2025 Apr 3;13(4):870. doi: 10.3390/biomedicines13040870.
5
Serum Catestatin Levels in Patients with Acne Vulgaris: Single-Center Prospective Study.寻常痤疮患者的血清卡替他汀水平:单中心前瞻性研究
Skin Appendage Disord. 2024 Dec;10(6):490-496. doi: 10.1159/000539224. Epub 2024 Jun 11.
6
Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease.生长分化因子-15血清浓度反映炎症性肠病患者的疾病严重程度和贫血情况。
World J Gastroenterol. 2024 Apr 7;30(13):1899-1910. doi: 10.3748/wjg.v30.i13.1899.
7
Plasma catestatin levels are related to metabolic parameters in patients with essential hypertension and type 2 diabetes mellitus.原发性高血压合并 2 型糖尿病患者的血浆卡特西坦水平与代谢参数相关。
Heart Vessels. 2024 Feb;39(2):144-159. doi: 10.1007/s00380-023-02318-w. Epub 2023 Sep 27.
8
Selected Serum Markers Associated with Pathogenesis and Clinical Course of Type 1 Diabetes in Pediatric Patients-The Effect of Disease Duration.与儿童1型糖尿病发病机制及临床病程相关的血清标志物——病程的影响
J Clin Med. 2023 Mar 9;12(6):2151. doi: 10.3390/jcm12062151.
9
Pathophysiology of Inflammatory Bowel Disease: Innate Immune System.炎症性肠病的病理生理学:固有免疫系统。
Int J Mol Sci. 2023 Jan 12;24(2):1526. doi: 10.3390/ijms24021526.
10
Serum Catestatin Level as a Stratification Assessment Tool in Non-Critical COVID-19 Patients.血清 Catestatin 水平作为非危重新冠肺炎患者的分层评估工具。
Int J Environ Res Public Health. 2023 Jan 9;20(2):1136. doi: 10.3390/ijerph20021136.

本文引用的文献

1
Catestatin reverses the hypertrophic effects of norepinephrine in H9c2 cardiac myoblasts by modulating the adrenergic signaling.加压素酶抑制剂通过调节肾上腺素能信号转导逆转去甲肾上腺素对 H9c2 心肌细胞的肥厚作用。
Mol Cell Biochem. 2020 Jan;464(1-2):205-219. doi: 10.1007/s11010-019-03661-1. Epub 2019 Dec 2.
2
Catestatin in defense of oxidative-stress-induced apoptosis: A novel mechanism by activating the beta2 adrenergic receptor and PKB/Akt pathway in ischemic-reperfused myocardium.在缺血再灌注心肌中,通过激活β2 肾上腺素能受体和 PKB/Akt 途径来抵抗氧化应激诱导的细胞凋亡:一种新的防御机制。
Peptides. 2020 Jan;123:170200. doi: 10.1016/j.peptides.2019.170200. Epub 2019 Nov 12.
3
Catestatin prevents endothelial inflammation and promotes thrombus resolution in acute pulmonary embolism in mice.钙抑肽可预防急性肺栓塞小鼠的内皮炎症并促进血栓溶解。
Biosci Rep. 2019 Nov 29;39(11). doi: 10.1042/BSR20192236.
4
Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study.急性失代偿性心力衰竭患者中的降钙素抑制肽:来自CATSTAT-HF研究的见解
J Clin Med. 2019 Jul 30;8(8):1132. doi: 10.3390/jcm8081132.
5
Elevated Muscle Sympathetic Nerve Activity Contributes to Central Artery Stiffness in Young and Middle-Age/Older Adults.肌肉交感神经活动升高导致中青年/老年人大动脉僵硬。
Hypertension. 2019 May;73(5):1025-1035. doi: 10.1161/HYPERTENSIONAHA.118.12462.
6
Serum catestatin concentrations are decreased in obese children and adolescents.肥胖儿童和青少年的血清卡特西坦浓度降低。
Pediatr Diabetes. 2019 Aug;20(5):549-555. doi: 10.1111/pedi.12825. Epub 2019 Apr 21.
7
Decreased circulating catestatin levels are associated with coronary artery disease: The emerging anti-inflammatory role.循环中钙抑素水平降低与冠状动脉疾病相关:新兴的抗炎作用。
Atherosclerosis. 2019 Feb;281:78-88. doi: 10.1016/j.atherosclerosis.2018.12.025. Epub 2018 Dec 24.
8
Catestatin as a Target for Treatment of Inflammatory Diseases.钙抑肽作为治疗炎症性疾病的靶点。
Front Immunol. 2018 Oct 4;9:2199. doi: 10.3389/fimmu.2018.02199. eCollection 2018.
9
Catestatin Regulates Epithelial Cell Dynamics to Improve Intestinal Inflammation.降钙素抑制肽调节上皮细胞动态变化以改善肠道炎症。
Vaccines (Basel). 2018 Sep 20;6(4):67. doi: 10.3390/vaccines6040067.
10
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.

炎症性肠病患者的血清抑癌素水平和动脉僵硬度参数升高。

Serum Catestatin Levels and Arterial Stiffness Parameters Are Increased in Patients with Inflammatory Bowel Disease.

作者信息

Zivkovic Piero Marin, Matetic Andrija, Tadin Hadjina Ivana, Rusic Doris, Vilovic Marino, Supe-Domic Daniela, Borovac Josip Andelo, Mudnic Ivana, Tonkic Ante, Bozic Josko

机构信息

Department of Gastroenterology, University Hospital of Split, 21000 Split, Croatia.

Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia.

出版信息

J Clin Med. 2020 Feb 26;9(3):628. doi: 10.3390/jcm9030628.

DOI:10.3390/jcm9030628
PMID:32110996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7141110/
Abstract

Catestatin (CST) is an important peptide in the pathophysiology of chronic inflammatory disorders. However, clinical studies on inflammatory bowel disease (IBD) patients are lacking. Our goal was to investigate CST concentrations in IBD patients compared to healthy subjects. Additionally, we aimed to determine arterial stiffness parameters in relation to CST. This cross-sectional study compared 80 IBD patients (45 Crohn's disease (CD) and 35 ulcerative colitis (UC) patients) with 75 control subjects. Serum CST levels were significantly higher in the IBD group compared to control subjects (11.29 ± 9.14 vs. 7.13 ± 6.08 ng/mL, 0.001) and in the UC group compared to CD patients (13.50 ± 9.58 vs. 9.03 ± 6.92 ng/mL, 0.021), irrespective of age and BMI. IBD patients exhibited significantly higher values of heart rate adjusted central augmentation index (cAIx-75) (14.88 ± 10.59 vs. 6.87 ± 9.50 %, 0.001) and pulse wave velocity (PWV) (8.06 ± 3.23 vs. 6.42 ± 1.47 m/s, 0.001) compared to control group. Furthermore, PWV was the only significant independent correlate of CST ( 1.20, 4.15, 0.001), while CST, PWV, cAIx-75, high-sensitivity C-reactive protein and BMI were significant predictors of positive IBD status (1.089 (1.022-1.161), 1.515 (1.166-1.968), 1.060 (1.024-1.097), 1.458 (1.116-1.906), 0.793 (0.683-0.920), respectively). Serum CST levels were significantly higher in IBD patients compared to controls and an independent positive correlation of CST with PWV existed. Therefore, it is possible that CST could have a role in the complex pathophysiology of IBD and its cardiovascular complications.

摘要

抑制素(CST)是慢性炎症性疾病病理生理学中的一种重要肽。然而,针对炎症性肠病(IBD)患者的临床研究尚缺乏。我们的目标是研究IBD患者与健康受试者相比的CST浓度。此外,我们旨在确定与CST相关的动脉僵硬度参数。这项横断面研究将80例IBD患者(45例克罗恩病(CD)和35例溃疡性结肠炎(UC)患者)与75名对照受试者进行了比较。与对照受试者相比,IBD组的血清CST水平显著更高(11.29±9.14对7.13±6.08 ng/mL,P<0.001),与CD患者相比,UC组的血清CST水平也显著更高(13.50±9.58对9.03±6.92 ng/mL,P = 0.021),且不受年龄和体重指数的影响。与对照组相比,IBD患者的心率校正中心增强指数(cAIx-75)(14.88±10.59对6.87±9.50%,P<0.001)和脉搏波速度(PWV)(8.06±3.23对6.42±1.47 m/s,P<0.001)的值显著更高。此外,PWV是CST的唯一显著独立相关因素(β = 1.20,95%CI:4.15,P<0.001),而CST、PWV、cAIx-75、高敏C反应蛋白和体重指数是IBD阳性状态的显著预测因素(分别为1.089(1.022 - 1.161)、1.515(1.166 - 1.968)、1.060(1.024 - 1.097)、1.458(1.116 - 1.906)、0.793(0.683 - 0.920))。与对照组相比,IBD患者的血清CST水平显著更高,且CST与PWV存在独立正相关。因此,CST可能在IBD及其心血管并发症的复杂病理生理学中发挥作用。